This is just my basic MONTHLY charting.
I have marked what I see as the POSSIBLE bottom (support).
I see overall DOWNTREND with possible reversal.
I have marked my potential BUY LEVELS for LONGS//CALLS.
Description: CDXC is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $7.5 - $8.2
2. Take profit: $11.02
3. Stop Loss: $7.06
4. Risk To Reward: 1 / 5
5. Accuracy Rating: 82%
New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients
New Phase 3 study results show added nutritional protocol reduces recovery time in mild-to-moderate COVID-19 patients
The addition of the nutritional protocol, or combined metabolic activators (CMA), to the Turkish...
Bullish Pennant
Pros:
Descending volume during formation
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 8
250RSI above 50
200MA ascending
Cons:
Volume during formation
Target:
PT = 14.94$
1000 Followers! Thank you all!
Thank you to those who donate Coins!
Stay Humble, have fun, make money!
As one of few micro-cap with real revenues (40% growth) blessed with huge market potential and very competent managment, I suspect the company will be bought out by one of the SPACs with too much cash but no real business. Patience is likely to be rewarded handsomely.
Volumes have been tripling for days, a prelude to some excitement to come?
After basing for many years, CDXC is showing signs of awakening. Stocks are being accumulated but not aggressively. It's one of few bio stocks with insider buying at the current price.
The co is likely on track doing $200 mil revenue in 2 or 3 years, 10X of the 200 mil revenue = 2 bil market cap, with about 62 mil shares O/S. Potentially huge valuation...
In this market where SPEC trades at billions with NO revenue, I like CDXC though I may be early. Yes it's not TSLA, yes Value does not work in this market but
With a tiny market cap of 290 mil and revenue growth at 40% (still early-stage market), I am betting with Li Ka Shing, one of the richest and other top 20 institutions including Blackrock who collectively...
Chromadex Corp. is a nutraceutical company. The firm engages in acquiring, developing and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products, and Analytical Reference Standards and Services. The Ingredients segment offers NIAGEN in an ingredient form to partners. The Consumer...
Possible breakout imminent from a year congestion channel
Weekly MACd and Histogram bullish move
Moving averages converging
Volume spiking
Chromadex Corp. is a nutraceutical company. The firm engages in acquiring, developing and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products,...
We have been watching $CDXC for quite awhile and the stock is on verge of a breakout. A move above $5 would be new 52-week highs and get the momentum players into the stock.
We are going in at $5.01 and not much of a stop will be needed. For those that use a money stop, 5% to 10% risk is sufficient.
About ChromaDex:
ChromaDex Corp. is a science-based integrated...
CDXC has formed a dragon or hammer candle. It is bouncing off the 200 day moving average making the price a bargain. The target price is $9.25 however I'll aim for the upper Bollinger Band for $5.57. Ill set my stop loss below the 200 day. This should offer a 15% return.
trend lines and a rising channel. EW count supports a retesting of the trend line with possible targets shown. If CDXC bounce off the trend line or one of the FB retracement targets, that is the time to go long. Oscillators suggest a minor correction is in store.
